Redox control of protein degradation

Redox Biology

Volumn 6, Issue , 2015, Pages 409-420

  Pajares, Marta ^a,b,c   Jiménez Moreno, Natalia ^a,b,c   Dias, Irundika H K ^d   Debelec, Bilge ^e   Vucetic, Milica ^f   Fladmark, Kari E ^g   Basaga, Huveyda ^h   Ribaric, Samo ⁱ   Milisav, Irina ^i,j   Cuadrado, Antonio ^a,b,c  

^a INSTITUTO DE INVESTIGACIONES BIOMÉDICAS ALBERTO SOLS   (Spain)

^b HOSPITAL UNIVERSITARIO LA PAZ IDIPAZ   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d ASTON UNIVERSITY   (United Kingdom)

^e EGE UNIVERSITY   (Turkey)

^f UNIVERSITY OF BELGRADE   (Serbia)

^g UNIVERSITY OF BERGEN   (Norway)

^h SABANCI UNIVERSITY   (Turkey)

ⁱ UNIVERSITY OF LJUBLJANA   (Slovenia)

^j Faculty of Health Sciences   (Slovenia)

more..

Author keywords

Autophagy; Proteasome; Protein oxidation; Proteolysis; Unfolded protein response

Indexed keywords

OXYPROTEIN; PROTEIN; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; NERVE PROTEIN; PROTEASOME; UBIQUITIN;

ALZHEIMER DISEASE; AUTOPHAGY; CELL SURVIVAL; CELL VIABILITY; HUMAN; NEUROPATHOLOGY; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PRION DISEASE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN HOMEOSTASIS; PROTEIN MODIFICATION; PROTEIN QUALITY; REVIEW; UNFOLDED PROTEIN RESPONSE; GENETICS; METABOLISM; OXIDATION REDUCTION REACTION; PATHOLOGY; PROTEIN PROCESSING; UBIQUITINATION;

ALZHEIMER DISEASE; AUTOPHAGY; HUMANS; NERVE TISSUE PROTEINS; OXIDATION-REDUCTION; PARKINSON DISEASE; PRION DISEASES; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEOLYSIS; REACTIVE OXYGEN SPECIES; UBIQUITIN; UBIQUITINATION; UNFOLDED PROTEIN RESPONSE;

EID: 84941793416     PISSN: 22132317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.redox.2015.07.003     Document Type: Review

References (157)

1. Murphy M.P. How mitochondria produce reactive oxygen species. Biochem. J. 2009, 417(1):1-13.
2. Haynes C.M., Titus E.A., Cooper A.A. Degradation of misfolded proteins prevents ER-derived oxidative stress and cell death. Mol. Cell 2004, 15(5):767-776.
3. Stolz D.B., et al. Peroxisomal localization of inducible nitric oxide synthase in hepatocytes. Hepatology 2002, 36(1):81-93.
4. Schrader M., Fahimi H.D. Mammalian peroxisomes and reactive oxygen species. Histochem. Cell Biol. 2004, 122(4):383-393.
5. Groeger G., et al. Stress-induced activation of Nox contributes to cell survival signalling via production of hydrogen peroxide. J. Neurochem. 2009, 109(5):1544-1554.
6. Love N.R., et al. Amputation-induced reactive oxygen species are required for successful Xenopus tadpole tail regeneration. Nat. Cell Biol. 2013, 15(2):222-228.
7. Block K., Gorin Y. Aiding and abetting roles of NOX oxidases in cellular transformation. Nat. Rev. Cancer 2012, 12(9):627-637.
8. Corcoran A., Cotter T.G. Redox regulation of protein kinases. FEBS J. 2013, 280(9):1944-1965.
9. Holmstrom K.M., Finkel T. Cellular mechanisms and physiological consequences of redox-dependent signalling. Nat. Rev. Mol. Cell Biol. 2014, 15(6):411-421.
10. Bhattacharyya A., et al. Oxidative stress: an essential factor in the pathogenesis of gastrointestinal mucosal diseases. Physiol. Rev. 2014, 94(2):329-354.
11. Ciechanover A. Intracellular protein degradation from a vague idea through the lysosome and the ubiquitin-proteasome system and on to human diseases and drug targeting: Nobel Lecture, December 8, 2004. Ann. N. Y. Acad. Sci. 2007, 1116:1-28.
12. Peters J.M., et al. Structural features of the 26S proteasome complex. J. Mol. Biol. 1993, 234(4):932-937.
13. Gray C.W., Slaughter C.A., DeMartino G.N. PA28 activator protein forms regulatory caps on proteasome stacked rings. J. Mol. Biol. 1994, 236(1):7-15.
14. Grune T., Reinheckel T., Davies K.J. Degradation of oxidized proteins in mammalian cells. FASEB J. 1997, 11(7):526-534.
15. Shringarpure R., Grune T., Davies K.J. Protein oxidation and 20S proteasome-dependent proteolysis in mammalian cells. Cell. Mol. Life Sci. 2001, 58(10):1442-1450.
16. Pickering A.M., et al. The immunoproteasome, the 20S proteasome and the PA28alphabeta proteasome regulator are oxidative-stress-adaptive proteolytic complexes. Biochem. J. 2010, 432(3):585-594.
17. Shang F., Taylor A. Oxidative stress and recovery from oxidative stress are associated with altered ubiquitin conjugating and proteolytic activities in bovine lens epithelial cells. Biochem. J. 1995, 307(Pt 1):297-303.
18. Reinheckel T., et al. Comparative resistance of the 20S and 26S proteasome to oxidative stress. Biochem. J. 1998, 335(Pt 3):637-642.
19. Reinheckel T., et al. Differential impairment of 20S and 26S proteasome activities in human hematopoietic K562 cells during oxidative stress. Arch. Biochem. Biophys. 2000, 377(1):65-68.
20. Zhang X., et al. The proteasome: a target of oxidative damage in cultured human retina pigment epithelial cells. Invest. Ophthalmol. Vis. Sci. 2008, 49(8):3622-3630.
21. Dudek E.J., et al. Selectivity of the ubiquitin pathway for oxidatively modified proteins: relevance to protein precipitation diseases. FASEB J. 2005, 19(12):1707-1709.
22. Lee B.H., et al. Enhancement of proteasome activity by a small-molecule inhibitor of USP14. Nature 2010, 467(7312):179-184.
23. Aiken C.T., et al. Oxidative stress-mediated regulation of proteasome complexes. Mol. Cell Proteom. 2011, 10(5). R110 006924.
24. Shang F., Taylor A. Ubiquitin-proteasome pathway and cellular responses to oxidative stress. Free Radic. Biol. Med. 2011, 51(1):5-16.
25. Wang G.L., et al. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc. Natl. Acad. Sci. USA 1995, 92(12):5510-5514.
26. Salceda S., et al. Complex role of protein phosphorylation in gene activation by hypoxia. Kidney Int. 1997, 51(2):556-559.
27. Jahngen-Hodge J., et al. Regulation of ubiquitin-conjugating enzymes by glutathione following oxidative stress. J. Biol. Chem. 1997, 272(45):28218-28226.
28. Yao D., et al. Nitrosative stress linked to sporadic Parkinson's disease: S-nitrosylation of parkin regulates its E3 ubiquitin ligase activity. Proc. Natl. Acad. Sci. USA 2004, 101(29):10810-10814.
29. Bulteau A.L., et al. Impairment of proteasome function upon UVA- and UVB-irradiation of human keratinocytes. Free Radic. Biol. Med. 2002, 32(11):1157-1170.
30. Ishii T., et al. Oxidative modification of proteasome: identification of an oxidation-sensitive subunit in 26S proteasome. Biochemistry 2005, 44(42):13893-13901.
31. Zmijewski J.W., Banerjee S., Abraham E. S-glutathionylation of the Rpn2 regulatory subunit inhibits 26S proteasomal function. J. Biol. Chem. 2009, 284(33):22213-22221.
32. Silva G.M., et al. Redox control of 20S proteasome gating. Antioxid. Redox Signal. 2012, 16(11):1183-1194.
33. Ullrich O., et al. Poly-ADP ribose polymerase activates nuclear proteasome to degrade oxidatively damaged histones. Proc. Natl. Acad. Sci. USA 1999, 96(11):6223-6228.
34. De Vos M., Schreiber V., Dantzer F. The diverse roles and clinical relevance of PARPs in DNA damage repair: current state of the art. Biochem. Pharmacol. 2012, 84(2):137-146.
35. Bose S., et al. Phosphorylation of 20S proteasome alpha subunit C8 (alpha7) stabilizes the 26S proteasome and plays a role in the regulation of proteasome complexes by gamma-interferon. Biochem. J. 2004, 378(Pt 1):177-184.
36. Um J.W., et al. ASK1 negatively regulates the 26S proteasome. J. Biol. Chem. 2010, 285(47):36434-36446.
37. Chondrogianni N., et al. Central role of the proteasome in senescence and survival of human fibroblasts: induction of a senescence-like phenotype upon its inhibition and resistance to stress upon its activation. J. Biol. Chem. 2003, 278(30):28026-28037.
38. Chen Q., et al. Ump1 extends yeast lifespan and enhances viability during oxidative stress: central role for the proteasome?. Free Radic. Biol. Med. 2006, 40(1):120-126.
39. Chondrogianni N., Gonos E.S. Overexpression of hUMP1/POMP proteasome accessory protein enhances proteasome-mediated antioxidant defence. Exp. Gerontol. 2007, 42(9):899-903.
40. Takabe W., et al. Chemical structure-dependent gene expression of proteasome subunits via regulation of the antioxidant response element. Free Radic. Res. 2006, 40(1):21-30.
41. Kapeta S., Chondrogianni N., Gonos E.S. Nuclear erythroid factor 2-mediated proteasome activation delays senescence in human fibroblasts. J. Biol. Chem. 2010, 285(11):8171-8184.
42. Lee C.S., et al. A proteasomal stress response: pre-treatment with proteasome inhibitors increases proteasome activity and reduces neuronal vulnerability to oxidative injury. J. Neurochem. 2004, 91(4):996-1006.
43. Klionsky D.J., Emr S.D. Autophagy as a regulated pathway of cellular degradation. Science 2000, 290(5497):1717-1721.
44. Yorimitsu T., Klionsky D.J. Autophagy: molecular machinery for self-eating. Cell Death Differ. 2005, 12(Suppl 2):S1542-S1552.
45. Cuervo A.M. Autophagy: in sickness and in health. Trends Cell Biol. 2004, 14(2):70-77.
46. Arias E., Cuervo A.M. Chaperone-mediated autophagy in protein quality control. Curr. Opin. Cell Biol. 2011, 23(2):184-189.
47. Kaushik S., Cuervo A.M. Chaperone-mediated autophagy: a unique way to enter the lysosome world. Trends Cell Biol. 2012, 22(8):407-417.
48. Li W.W., Li J., Bao J.K. Microautophagy: lesser-known self-eating. Cell. Mol. Life Sci. 2012, 69(7):1125-1136.
49. Chiang H.S., Maric M. Lysosomal thiol reductase negatively regulates autophagy by altering glutathione synthesis and oxidation. Free Radic. Biol. Med. 2011, 51(3):688-699.
50. Desideri E., Filomeni G., Ciriolo M.R. Glutathione participates in the modulation of starvation-induced autophagy in carcinoma cells. Autophagy 2012, 8(12):1769-1781.
51. Cuervo A.M., et al. IkappaB is a substrate for a selective pathway of lysosomal proteolysis. Mol. Biol. Cell 1998, 9(8):1995-2010.
52. Kiffin R., et al. Activation of chaperone-mediated autophagy during oxidative stress. Mol. Biol. Cell. 2004, 15(11):4829-4840.
53. Kaushik S., Cuervo A.M. Autophagy as a cell-repair mechanism: activation of chaperone-mediated autophagy during oxidative stress. Mol. Asp. Med. 2006, 27(5-6):444-454.
54. Massey A.C., et al. Consequences of the selective blockage of chaperone-mediated autophagy. Proc. Natl. Acad. Sci. USA 2006, 103(15):5805-5810.
55. Zhang C., Cuervo A.M. Restoration of chaperone-mediated autophagy in aging liver improves cellular maintenance and hepatic function. Nat. Med. 2008, 14(9):959-965.
56. Sugiura A., et al. A new pathway for mitochondrial quality control: mitochondrial-derived vesicles. EMBO J. 2014, 33(19):2142-2156.
57. Soubannier V., et al. A vesicular transport pathway shuttles cargo from mitochondria to lysosomes. Curr. Biol. 2012, 22(2):135-141.
58. Soubannier V., et al. Reconstitution of mitochondria derived vesicle formation demonstrates selective enrichment of oxidized cargo. PLoS One 2012, 7(12):e52830.
59. McLelland G.L., et al. Parkin and PINK1 function in a vesicular trafficking pathway regulating mitochondrial quality control. EMBO J. 2014, 33(4):282-295.
60. Pietrocola F., et al. Regulation of autophagy by stress-responsive transcription factors. Semin. Cancer Biol. 2013, 23(5):310-322.
61. Ichimura Y., et al. Phosphorylation of p62 activates the Keap1-Nrf2 pathway during selective autophagy. Mol. Cell 2013, 51(5):618-631.
62. Nezis I.P., Stenmark H. p62 At the interface of autophagy, oxidative stress signaling, and cancer. Antioxid. Redox Signal. 2012, 17(5):786-793.
63. Jo C., et al. Nrf2 reduces levels of phosphorylated tau protein by inducing autophagy adaptor protein NDP52. Nat. Commun. 2014, 5:3496.
64. Cuervo-Escobar S., et al. T-cell populations and cytokine expression are impaired in thymus and spleen of protein malnourished BALB/c mice infected with leishmania infantum. PLoS One 2014, 9(12):e114584.
65. Rodriguez-Navarro J.A., et al. Trehalose ameliorates dopaminergic and tau pathology in parkin deleted/tau overexpressing mice through autophagy activation. Neurobiol. Dis. 2010, 39(3):423-438.
66. Bensaad K., Cheung E.C., Vousden K.H. Modulation of intracellular ROS levels by TIGAR controls autophagy. EMBO J. 2009, 28(19):3015-3026.
67. Dunlop R.A., Brunk U.T., Rodgers K.J. Oxidized proteins: mechanisms of removal and consequences of accumulation. IUBMB Life 2009, 61(5):522-527.
68. Ryhanen T., et al. Crosstalk between Hsp70 molecular chaperone, lysosomes and proteasomes in autophagy-mediated proteolysis in human retinal pigment epithelial cells. J. Cell. Mol. Med. 2009, 13(9B):3616-3631.
69. Terman A., Brunk U.T. Lipofuscin. Int. J. Biochem. Cell Biol. 2004, 36(8):1400-1404.
70. Hohn A., Grune T. Lipofuscin: formation, effects and role of macroautophagy. Redox Biol. 2013, 1(1):140-144.
71. Wan F.Y., Wang Y.N., Zhang G.J. The influence of oxidation of membrane thiol groups on lysosomal proton permeability. Biochem. J. 2001, 360(Pt 2):355-362.
72. Terman A., Abrahamsson N., Brunk U.T. Ceroid/lipofuscin-loaded human fibroblasts show increased susceptibility to oxidative stress. Exp. Gerontol. 1999, 34(6):755-770.
73. Olejnicka B.T., et al. Beta-cells, oxidative stress, lysosomal stability, and apoptotic/necrotic cell death. Antioxid. Redox Signal. 1999, 1(3):305-315.
74. Brunk U.T., Terman A. Lipofuscin: mechanisms of age-related accumulation and influence on cell function. Free Radic. Biol. Med. 2002, 33(5):611-619.
75. Roberg K., Johansson U., Ollinger K. Lysosomal release of cathepsin D precedes relocation of cytochrome c and loss of mitochondrial transmembrane potential during apoptosis induced by oxidative stress. Free Radic. Biol. Med. 1999, 27(11-12):1228-1237.
76. Yuan X.M., et al. Lysosomal destabilization during macrophage damage induced by cholesterol oxidation products. Free Radic. Biol. Med. 2000, 28(2):208-218.
77. Pourahmad J., Ross S., O'Brien P.J. Lysosomal involvement in hepatocyte cytotoxicity induced by Cu(2+) but not Cd(2+). Free Radic. Biol. Med. 2001, 30(1):89-97.
78. Yu L., et al. Autophagic programmed cell death by selective catalase degradation. Proc. Natl. Acad. Sci. USA 2006, 103(13):4952-4957.
79. Kurz T., Terman A., Brunk U.T. Autophagy, ageing and apoptosis: the role of oxidative stress and lysosomal iron. Arch. Biochem. Biophys. 2007, 462(2):220-230.
80. Chen Y., Brandizzi F. IRE1: ER stress sensor and cell fate executor. Trends Cell Biol. 2013, 23(11):547-555.
81. Reid D.W., et al. The unfolded protein response triggers selective mRNA release from the endoplasmic reticulum. Cell 2014, 158(6):1362-1374.
82. Wang S., Kaufman R.J. The impact of the unfolded protein response on human disease. J. Cell Biol. 2012, 197(7):857-867.
83. Cao S.S., Kaufman R.J. Unfolded protein response. Curr. Biol. 2012, 22(16):R622-R626.
84. Sovolyova N., et al. Stressed to death - mechanisms of ER stress-induced cell death. Biol. Chem. 2014, 395(1):1-13.
85. Xu W., et al. Nitric oxide induces coupling of mitochondrial signalling with the endoplasmic reticulum stress response. Nat. Cell Biol. 2004, 6(11):1129-1134.
86. Malhotra J.D., Kaufman R.J. Endoplasmic reticulum stress and oxidative stress: a vicious cycle or a double-edged sword?. Antioxid. Redox Signal. 2007, 9(12):2277-2293.
87. Yoshida H., et al. ATF6 activated by proteolysis binds in the presence of NF-Y (CBF) directly to the cis-acting element responsible for the mammalian unfolded protein response. Mol. Cell. Biol. 2000, 20(18):6755-6767.
88. Deldicque L. Endoplasmic reticulum stress in human skeletal muscle: any contribution to sarcopenia?. Front. Physiol. 2013, 4:236.
89. Nadanaka S., et al. Role of disulfide bridges formed in the luminal domain of ATF6 in sensing endoplasmic reticulum stress. Mol. Cell. Biol. 2007, 27(3):1027-1043.
90. Marciniak S.J., et al. CHOP induces death by promoting protein synthesis and oxidation in the stressed endoplasmic reticulum. Genes Dev. 2004, 18(24):3066-3077.
91. Ghosh A.P., et al. CHOP potentially co-operates with FOXO3a in neuronal cells to regulate PUMA and BIM expression in response to ER stress. PLoS One 2012, 7(6):e39586.
92. Chiribau C.B., et al. Molecular symbiosis of CHOP and C/EBP beta isoform LIP contributes to endoplasmic reticulum stress-induced apoptosis. Mol. Cell. Biol. 2010, 30(14):3722-3731.
93. Cullinan S.B., et al. Nrf2 is a direct PERK substrate and effector of PERK-dependent cell survival. Mol. Cell. Biol. 2003, 23(20):7198-7209.
94. Cullinan S.B., Diehl J.A. PERK-dependent activation of Nrf2 contributes to redox homeostasis and cell survival following endoplasmic reticulum stress. J. Biol. Chem. 2004, 279(19):20108-20117.
95. Desagher S., et al. Genes regulated in neurons undergoing transcription-dependent apoptosis belong to signaling pathways rather than the apoptotic machinery. J. Biol. Chem. 2005, 280(7):5693-5702.
96. Digaleh H., Kiaei M., Khodagholi F. Nrf2 and Nrf1 signaling and ER stress crosstalk: implication for proteasomal degradation and autophagy. Cell. Mol. Life Sci. 2013, 70(24):4681-4694.
97. Dufey E., et al. Cellular mechanisms of endoplasmic reticulum stress signaling in health and disease. 1. An overview. Am. J. Physiol. Cell Physiol. 2014, 307(7):C582-C594.
98. Higa A., Chevet E. Redox signaling loops in the unfolded protein response. Cell. Signal. 2012, 24(8):1548-1555.
99. Cao S.S., Kaufman R.J. Endoplasmic reticulum stress and oxidative stress in cell fate decision and human disease. Antioxid. Redox Signal. 2014, 21(3):396-413.
100. 2 produced during disulphide formation. J. Cell Sci. 2010, 123(Pt 15):2672-2679.
101. Gorlach A., Klappa P., Kietzmann T. The endoplasmic reticulum: folding, calcium homeostasis, signaling, and redox control. Antioxid. Redox Signal. 2006, 8(9-10):1391-1418.
102. Milhavet O., Lehmann S. Oxidative stress and the prion protein in transmissible spongiform encephalopathies. Brain Res. Brain Res. Rev. 2002, 38(3):328-339.
103. Brown D.R. Neurodegeneration and oxidative stress: prion disease results from loss of antioxidant defence. Folia Neuropathol. 2005, 43(4):229-243.
104. 2+, but is a sacrificial quencher of hydroxyl radicals. Free Radic. Biol. Med. 2007, 42(1):79-89.
105. Cui Z.J., Han Z.Q., Li Z.Y. Modulating protein activity and cellular function by methionine residue oxidation. Amino Acids 2012, 43(2):505-517.
106. Elmallah M.I., et al. Impact of methionine oxidation as an initial event on the pathway of human prion protein conversion. Prion 2013, 7(5):404-411.
107. Younan N.D., et al. Methionine oxidation perturbs the structural core of the prion protein and suggests a generic misfolding pathway. J. Biol. Chem. 2012, 287(34):28263-28275.
108. Caughey B.W., et al. Secondary structure analysis of the scrapie-associated protein PrP 27-30 in water by infrared spectroscopy. Biochemistry 1991, 30(31):7672-7680.
109. Abid K., Soto C. The intriguing prion disorders. Cell. Mol. Life Sci 2006, 63(19-20):2342-2351.
110. Thellung S., et al. Human PrP90-231-induced cell death is associated with intracellular accumulation of insoluble and protease-resistant macroaggregates and lysosomal dysfunction. Cell Death Dis. 2011, 2:e138.
111. Chiovitti K., et al. Intracellular accumulation of a mild-denatured monomer of the human PrP fragment 90-231, as possible mechanism of its neurotoxic effects. J. Neurochem. 2007, 103(6):2597-2609.
112. Borger E., et al. Mitochondrial beta-amyloid in Alzheimer's disease. Biochem. Soc. Trans. 2011, 39(4):868-873.
113. Coskun P., et al. A mitochondrial etiology of Alzheimer and Parkinson disease. Biochim. Biophys. Acta 2012, 1820(5):553-564.
114. Siskova Z., et al. Morphological and functional abnormalities in mitochondria associated with synaptic degeneration in prion disease. Am. J. Pathol. 2010, 177(3):1411-1421.
115. Gandy S. The role of cerebral amyloid beta accumulation in common forms of Alzheimer disease. J. Clin. Invest. 2005, 115(5):1121-1129.
116. Necula M., et al. Small molecule inhibitors of aggregation indicate that amyloid beta oligomerization and fibrillization pathways are independent and distinct. J. Biol. Chem. 2007, 282(14):10311-10324.
117. Butterfield D.A., et al. In vivo oxidative stress in brain of Alzheimer disease transgenic mice: requirement for methionine 35 in amyloid beta-peptide of APP. Free Radic. Biol. Med. 2010, 48(1):136-144.
118. Nixon R.A. Autophagy, amyloidogenesis and Alzheimer disease. J. Cell Sci. 2007, 120(Pt 23):4081-4091.
119. Pickford F., et al. The autophagy-related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid beta accumulation in mice. J. Clin. Invest. 2008, 118(6):2190-2199.
120. Salminen A., et al. Impaired autophagy and APP processing in Alzheimer's disease: the potential role of Beclin 1 interactome. Prog. Neurobiol. 2013, 106-107:33-54.
121. Friedman L.G., Qureshi Y.H., Yu W.H. Promoting autophagic clearance: viable therapeutic targets in Alzheimer's disease. Neurotherapeutics 2015, 12(1):94-108.
122. Zhou F., et al. Luteolin reduces zinc-induced tau phosphorylation at Ser262/356 in an ROS-dependent manner in SH-SY5Y cells. Biol. Trace Elem. Res. 2012, 149(2):273-279.
123. Rhein V., et al. Amyloid-beta and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer's disease mice. Proc. Natl. Acad. Sci. USA 2009, 106(47):20057-20062.
124. Grune T., et al. Tau protein degradation is catalyzed by the ATP/ubiquitin-independent 20S proteasome under normal cell conditions. Arch. Biochem. Biophys. 2010, 500(2):181-188.
125. Saidi L.J., et al. Carboxy terminus heat shock protein 70 interacting protein reduces tau-associated degenerative changes. J. Alzheimers Dis. 2015, 44(3):937-947.
126. Keller J.N., Hanni K.B., Markesbery W.R. Impaired proteasome function in Alzheimer's disease. J. Neurochem. 2000, 75(1):436-439.
127. Keck S., et al. Proteasome inhibition by paired helical filament-tau in brains of patients with Alzheimer's disease. J. Neurochem. 2003, 85(1):115-122.
128. Wang Y., et al. Synergy and antagonism of macroautophagy and chaperone-mediated autophagy in a cell model of pathological tau aggregation. Autophagy 2010, 6(1):182-183.
129. Lee M.J., Lee J.H., Rubinsztein D.C. Tau degradation: the ubiquitin-proteasome system versus the autophagy-lysosome system. Prog. Neurobiol. 2013, 105:49-59.
130. Clayton D.F., George J.M. Synucleins in synaptic plasticity and neurodegenerative disorders. J. Neurosci. Res. 1999, 58(1):120-129.
131. Clayton D.F., George J.M. The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease. Trends Neurosci. 1998, 21(6):249-254.
132. Spencer B., et al. Beclin 1 gene transfer activates autophagy and ameliorates the neurodegenerative pathology in alpha-synuclein models of Parkinson's and Lewy body diseases. J. Neurosci. 2009, 29(43):13578-13588.
133. Fortin D.L., et al. Neural activity controls the synaptic accumulation of alpha-synuclein. J. Neurosci. 2005, 25(47):10913-10921.
134. Martinez-Vicente M., et al. Dopamine-modified alpha-synuclein blocks chaperone-mediated autophagy. J. Clin. Invest. 2008, 118(2):777-788.
135. Stefanis L., et al. Expression of A53T mutant but not wild-type alpha-synuclein in PC12 cells induces alterations of the ubiquitin-dependent degradation system, loss of dopamine release, and autophagic cell death. J. Neurosci. 2001, 21(24):9549-9560.
136. Stefanis L. Alpha-synuclein in Parkinson's disease. Cold Spring Harb Perspect. Med. 2012, 2(2):a009399.
137. Hokenson M.J., et al. Role of individual methionines in the fibrillation of methionine-oxidized alpha-synuclein. Biochemistry 2004, 43(15):4621-4633.
138. Leong S.L., et al. Formation of dopamine-mediated alpha-synuclein-soluble oligomers requires methionine oxidation. Free Radic. Biol. Med. 2009, 46(10):1328-1337.
139. Lynch-Day M.A., et al. The role of autophagy in Parkinson's disease. Cold Spring Harb Perspect. Med. 2012, 2(4):a009357.
140. Winslow A.R., et al. Alpha-synuclein impairs macroautophagy: implications for Parkinson's disease. J. Cell Biol. 2010, 190(6):1023-1037.
141. Schapira A.H. Mitochondria in the aetiology and pathogenesis of Parkinson's disease. Lancet Neurol. 2008, 7(1):97-109.
142. Moscovitz O., et al. The Parkinson's-associated protein DJ-1 regulates the 20S proteasome. Nat. Commun. 2015, 6:6609.
143. Scherz-Shouval R., et al. Reactive oxygen species are essential for autophagy and specifically regulate the activity of Atg4. EMBO J. 2007, 26(7):1749-1760.
144. Zmijewski J.W., et al. Exposure to hydrogen peroxide induces oxidation and activation of AMP-activated protein kinase. J. Biol. Chem. 2010, 285(43):33154-33164.
145. Emerling B.M., et al. Hypoxic activation of AMPK is dependent on mitochondrial ROS but independent of an increase in AMP/ATP ratio. Free Radic. Biol. Med. 2009, 46(10):1386-1391.
146. Kim J., et al. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat. Cell Biol. 2011, 13(2):132-141.
147. Alexander A., Kim J., Walker C.L. ATM engages the TSC2/mTORC1 signaling node to regulate autophagy. Autophagy 2010, 6(5):672-673.
148. Fujino G., et al. Thioredoxin and TRAF family proteins regulate reactive oxygen species-dependent activation of ASK1 through reciprocal modulation of the N-terminal homophilic interaction of ASK1. Mol. Cell. Biol. 2007, 27(23):8152-8163.
149. Wei Y., et al. JNK1-mediated phosphorylation of Bcl-2 regulates starvation-induced autophagy. Mol. Cell 2008, 30(6):678-688.
150. Kaminskyy V.O., Zhivotovsky B. Free radicals in cross talk between autophagy and apoptosis. Antioxid. Redox Signal. 2014, 21(1):86-102.
151. Sarkar S., et al. Complex inhibitory effects of nitric oxide on autophagy. Mol. Cell 2011, 43(1):19-32.
152. Wang R.C., et al. Akt-mediated regulation of autophagy and tumorigenesis through Beclin 1 phosphorylation. Science 2012, 338(6109):956-959.
153. Numajiri N., et al. On-off system for PI3-kinase-Akt signaling through S-nitrosylation of phosphatase with sequence homology to tensin (PTEN). Proc. Natl. Acad. Sci. USA 2011, 108(25):10349-10354.
154. Wani W.Y., et al. Regulation of autophagy by protein post-translational modification. Lab. Invest. 2015, 95(1):14-25.
155. Bullen J.W., et al. Cross-talk between two essential nutrient-sensitive enzymes: O-GlcNAc transferase (OGT) and AMP-activated protein kinase (AMPK). J. Biol. Chem. 2014, 289(15):10592-10606.
156. Ma Q. Role of nrf2 in oxidative stress and toxicity. Annu. Rev. Pharmacol. Toxicol. 2013, 53:401-426.
157. Rojo A.I., et al. Redox control of microglial function: molecular mechanisms and functional significance. Antioxid. Redox Signal. 2014, 21(12):1766-1801.